WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics has raised $26.0M in total funding. The most recent round was Series B. The last funding was announced in October 2026.
WhiteLab Genomics's investors include AVP, Y Combinator, Omnes Capital, Debiopharm Group, Blast. Club.
WhiteLab Genomics is headquartered in Paris, France.
WhiteLab Genomics develops digital tools that help gene and cell therapy companies develop cheaper drugs faster.
WhiteLab Genomics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"WhiteLab Genomics — Funding & Investors." VCBacked, October 5, 2026, https://www.vcbacked.co/company/whitelab-genomics. Accessed November 14, 2026.
VCBacked. (2026). WhiteLab Genomics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/whitelab-genomics
{{cite web |title=WhiteLab Genomics — Funding & Investors |url=https://www.vcbacked.co/company/whitelab-genomics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at WhiteLab Genomics? Request a listing update